Guidelines for the investigation and management of recurrent pregnancy loss (RPL) have been developed in Europe, USA and UK, but there is currently no Australasian guideline. The Australasian Certificate of Reproductive Endocrinology and Infertility Consensus Expert Panel on Trial Evidence group has prepared a two-part guideline to provide guidance on the management of RPL.

Historic vote endorses equal access to fertility services

An alliance of Australia’s peak fertility associations has officially endorsed an expanded definition of infertility, paving the way for equal access to reproductive care regardless of relationship status, sexual orientation, or gender identity.

This advice should be read in conjunction with the ANZSREI statement on the use of vaccines for SARS Cov-2 during fertility treatment.

ANZSREI supports the introduction of legislative change and implementation of mitochondrial donation for the reduction of transmission of mitochondrial disease.

Yes – the vaccine will protect you from COVID-19. COVID-19 vaccines provoke an immune response to proteins associated with the SARS Cov2 virus.

ANZSREI is the society of specialist obstetricians and gynaecologists who have undertaken further training in reproductive endocrinology and infertility and therefore considered to be experts in the assessment and treatment of infertility.

ANZSREI President Prof Michael Chapman with Guest Speaker Dr David Adamson (USA), “Global trends in ART”

ANZSREI President Prof Michael Chapman with Guest Speaker Prof Joop Laven (Netherlands), “Menopause: Time for a new paradigm?”

9th Annual CREI Meeting 5-7 August 2016 Sheraton Darling Harbour, Sydney, Australia

10th annual ANZSREI Conference 4-6 August 2017 Sydney, Australia